We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In an usual move, the Institute for Clinical and Economic Review (ICER) quickly withdrew a draft report that questioned the cost-effectiveness of three rheumatoid arthritis treatments, saying that it needs to reconsider its approach. Read More
President Trump hinted that a drug importation proposal is coming soon from HHS, during a Thursday speech on an executive order aimed at improving Medicare. Read More
The expanded recall included an additional three lots of losartan potassium tablets and two lots of losartan potassium/hydrocholorothiazide tablets. Read More
The FDA warned manufacturers of ranitidine products not to use a high-temperature test for N-Nitrosodimethylamine (NDMA) because it actually generates high levels of the impurity. Read More
The FDA issued a warning letter to Lupin Pharmaceuticals over repeated failures at its Mandideep site near Bhopal in central India, including inadequate out-of-specification investigations. Read More